PARP1 and cancer: ATM inhibition, ATR inhibition, Chk1 inhibition, PARP inhibition, and WEE1 inhibition have all been shown to lead to cGAS-STING pathway activation and potentiation of cancer immunotherapy [176,177,178,179,180,181].